Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 22 | 2024 | 1136 | 2.980 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2023 | 3333 | 2.270 |
Why?
|
Diabetes Mellitus | 27 | 2021 | 5884 | 2.020 |
Why?
|
Hypoglycemic Agents | 15 | 2024 | 3149 | 1.930 |
Why?
|
Medical Records Systems, Computerized | 13 | 2010 | 1191 | 1.750 |
Why?
|
Data Mining | 5 | 2019 | 553 | 1.720 |
Why?
|
Medication Errors | 10 | 2014 | 783 | 1.430 |
Why?
|
Electronic Health Records | 21 | 2021 | 4763 | 1.410 |
Why?
|
Insulin | 11 | 2024 | 6592 | 1.380 |
Why?
|
Hypoglycemia | 5 | 2024 | 888 | 1.370 |
Why?
|
Counseling | 5 | 2019 | 1550 | 1.360 |
Why?
|
Treatment Refusal | 4 | 2020 | 430 | 1.330 |
Why?
|
Antihypertensive Agents | 10 | 2023 | 2063 | 1.200 |
Why?
|
Electronic Prescribing | 4 | 2014 | 114 | 1.200 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 12281 | 1.090 |
Why?
|
Medical Records | 6 | 2012 | 1407 | 1.050 |
Why?
|
Hypertension | 15 | 2023 | 8595 | 1.010 |
Why?
|
Medication Reconciliation | 3 | 2018 | 151 | 0.930 |
Why?
|
Software | 11 | 2018 | 4420 | 0.920 |
Why?
|
Blood Pressure Determination | 3 | 2015 | 641 | 0.910 |
Why?
|
Incretins | 1 | 2024 | 103 | 0.880 |
Why?
|
Documentation | 8 | 2017 | 892 | 0.870 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 159 | 0.840 |
Why?
|
Primary Health Care | 9 | 2019 | 4649 | 0.830 |
Why?
|
Blood Glucose | 9 | 2024 | 6375 | 0.790 |
Why?
|
Hyperkalemia | 1 | 2023 | 231 | 0.720 |
Why?
|
Life Style | 5 | 2019 | 3888 | 0.710 |
Why?
|
Hypercholesterolemia | 4 | 2013 | 1155 | 0.710 |
Why?
|
Blood Pressure | 9 | 2019 | 8523 | 0.710 |
Why?
|
Medication Adherence | 2 | 2024 | 2163 | 0.710 |
Why?
|
Hyperaldosteronism | 1 | 2023 | 244 | 0.700 |
Why?
|
Medication Systems, Hospital | 4 | 2008 | 154 | 0.690 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2024 | 334 | 0.680 |
Why?
|
Coronary Artery Disease | 7 | 2024 | 6661 | 0.670 |
Why?
|
Office Visits | 4 | 2011 | 597 | 0.660 |
Why?
|
Forms and Records Control | 2 | 2011 | 158 | 0.630 |
Why?
|
Retrospective Studies | 41 | 2024 | 80301 | 0.630 |
Why?
|
Metformin | 2 | 2024 | 912 | 0.620 |
Why?
|
Physicians, Primary Care | 5 | 2020 | 624 | 0.590 |
Why?
|
User-Computer Interface | 6 | 2019 | 1402 | 0.570 |
Why?
|
Diabetes Complications | 3 | 2020 | 1342 | 0.560 |
Why?
|
Medical Order Entry Systems | 4 | 2010 | 522 | 0.550 |
Why?
|
Aldosterone | 5 | 2023 | 868 | 0.550 |
Why?
|
Continuity of Patient Care | 5 | 2011 | 1067 | 0.530 |
Why?
|
Cholesterol | 4 | 2018 | 2925 | 0.520 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 988 | 0.490 |
Why?
|
Hyperglycemia | 2 | 2017 | 1380 | 0.480 |
Why?
|
Databases, Factual | 5 | 2024 | 8018 | 0.470 |
Why?
|
Algorithms | 15 | 2021 | 13967 | 0.470 |
Why?
|
Patient Compliance | 3 | 2010 | 2689 | 0.470 |
Why?
|
Decision Support Systems, Clinical | 5 | 2023 | 1162 | 0.460 |
Why?
|
Bariatric Surgery | 2 | 2021 | 1006 | 0.450 |
Why?
|
Ambulatory Care Information Systems | 2 | 2011 | 88 | 0.440 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15740 | 0.440 |
Why?
|
Narration | 3 | 2012 | 218 | 0.420 |
Why?
|
Vocabulary, Controlled | 3 | 2014 | 167 | 0.420 |
Why?
|
Humans | 110 | 2024 | 760261 | 0.420 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2296 | 0.410 |
Why?
|
Information Storage and Retrieval | 4 | 2017 | 821 | 0.410 |
Why?
|
Fees and Charges | 1 | 2013 | 191 | 0.410 |
Why?
|
Data Collection | 4 | 2010 | 3317 | 0.410 |
Why?
|
Ambulatory Care | 3 | 2020 | 2783 | 0.400 |
Why?
|
Emergencies | 1 | 2018 | 1217 | 0.390 |
Why?
|
Medication Systems | 1 | 2010 | 31 | 0.360 |
Why?
|
Risk Reduction Behavior | 2 | 2015 | 1109 | 0.360 |
Why?
|
Laboratories, Hospital | 1 | 2012 | 193 | 0.360 |
Why?
|
Aged | 39 | 2024 | 168995 | 0.350 |
Why?
|
Middle Aged | 46 | 2024 | 220175 | 0.350 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1287 | 0.350 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 385 | 0.350 |
Why?
|
Home Nursing | 1 | 2010 | 92 | 0.340 |
Why?
|
Subject Headings | 1 | 2008 | 17 | 0.330 |
Why?
|
Male | 56 | 2024 | 359413 | 0.320 |
Why?
|
Hospital Mortality | 5 | 2021 | 5420 | 0.310 |
Why?
|
Hospitalization | 5 | 2022 | 10761 | 0.310 |
Why?
|
Pattern Recognition, Automated | 3 | 2008 | 988 | 0.310 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 488 | 0.300 |
Why?
|
Medical History Taking | 2 | 2008 | 773 | 0.300 |
Why?
|
ROC Curve | 4 | 2021 | 3568 | 0.300 |
Why?
|
Warfarin | 2 | 2017 | 1516 | 0.290 |
Why?
|
Female | 55 | 2024 | 391011 | 0.290 |
Why?
|
Drug Utilization Review | 1 | 2008 | 251 | 0.290 |
Why?
|
Logistic Models | 2 | 2019 | 13311 | 0.290 |
Why?
|
Physicians | 4 | 2010 | 4590 | 0.290 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 670 | 0.280 |
Why?
|
Drug Prescriptions | 3 | 2017 | 1673 | 0.280 |
Why?
|
Appointments and Schedules | 1 | 2010 | 443 | 0.270 |
Why?
|
Cohort Studies | 12 | 2024 | 41317 | 0.270 |
Why?
|
Diagnostic Tests, Routine | 1 | 2012 | 785 | 0.270 |
Why?
|
Heart Failure | 5 | 2023 | 11835 | 0.260 |
Why?
|
Multivariate Analysis | 7 | 2021 | 12156 | 0.260 |
Why?
|
Lipoprotein-X | 1 | 2005 | 5 | 0.250 |
Why?
|
Internet | 4 | 2002 | 3074 | 0.250 |
Why?
|
Intensive Care Units | 1 | 2018 | 3737 | 0.250 |
Why?
|
Prediabetic State | 2 | 2024 | 550 | 0.250 |
Why?
|
Database Management Systems | 2 | 2006 | 258 | 0.230 |
Why?
|
Adult | 23 | 2024 | 219847 | 0.230 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2024 | 91 | 0.230 |
Why?
|
Renin | 2 | 2023 | 636 | 0.230 |
Why?
|
Certification | 1 | 2008 | 423 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2421 | 0.230 |
Why?
|
Databases, Genetic | 2 | 2018 | 1739 | 0.230 |
Why?
|
Anticoagulants | 3 | 2017 | 4896 | 0.220 |
Why?
|
Biomedical Research | 3 | 2020 | 3421 | 0.220 |
Why?
|
Mineralocorticoids | 1 | 2023 | 38 | 0.220 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2003 | 60 | 0.220 |
Why?
|
Health Personnel | 1 | 2017 | 3310 | 0.220 |
Why?
|
Quality of Health Care | 2 | 2018 | 4361 | 0.220 |
Why?
|
Amiloride | 1 | 2022 | 116 | 0.210 |
Why?
|
Research Personnel | 2 | 2018 | 584 | 0.210 |
Why?
|
Sequence Homology | 1 | 2002 | 195 | 0.210 |
Why?
|
Lisinopril | 1 | 2022 | 55 | 0.210 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 822 | 0.210 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2024 | 1583 | 0.200 |
Why?
|
Inpatients | 3 | 2022 | 2578 | 0.200 |
Why?
|
Registries | 9 | 2023 | 8449 | 0.190 |
Why?
|
Drug Approval | 1 | 2008 | 816 | 0.190 |
Why?
|
Atherosclerosis | 3 | 2023 | 3524 | 0.190 |
Why?
|
Withholding Treatment | 2 | 2017 | 613 | 0.190 |
Why?
|
Ibuprofen | 1 | 2022 | 229 | 0.180 |
Why?
|
Hyponatremia | 1 | 2003 | 281 | 0.180 |
Why?
|
Time Factors | 8 | 2024 | 40133 | 0.180 |
Why?
|
Hemorrhage | 2 | 2017 | 3604 | 0.180 |
Why?
|
Thromboembolism | 2 | 2017 | 1016 | 0.180 |
Why?
|
Body Mass Index | 3 | 2015 | 12901 | 0.180 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2064 | 0.180 |
Why?
|
Endocardial Cushion Defects | 1 | 2000 | 43 | 0.180 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2022 | 161 | 0.180 |
Why?
|
Risk Factors | 17 | 2024 | 74269 | 0.180 |
Why?
|
Clinical Pharmacy Information Systems | 3 | 2009 | 102 | 0.180 |
Why?
|
Medical Errors | 1 | 2008 | 1255 | 0.180 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2021 | 96 | 0.180 |
Why?
|
Situs Inversus | 1 | 2000 | 63 | 0.170 |
Why?
|
Administration, Oral | 3 | 2024 | 4044 | 0.170 |
Why?
|
Artificial Intelligence | 3 | 2008 | 2557 | 0.170 |
Why?
|
Proteinuria | 1 | 2023 | 594 | 0.170 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 1093 | 0.160 |
Why?
|
Thiazolidinediones | 1 | 2022 | 465 | 0.160 |
Why?
|
United States | 17 | 2024 | 72363 | 0.160 |
Why?
|
Computer-Assisted Instruction | 2 | 2000 | 362 | 0.160 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58947 | 0.160 |
Why?
|
Glomerular Filtration Rate | 2 | 2022 | 2178 | 0.160 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2696 | 0.160 |
Why?
|
Potassium | 1 | 2023 | 1318 | 0.160 |
Why?
|
Massachusetts | 7 | 2020 | 8805 | 0.160 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1521 | 0.160 |
Why?
|
Renin-Angiotensin System | 1 | 2023 | 739 | 0.150 |
Why?
|
Directive Counseling | 1 | 2019 | 170 | 0.150 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 853 | 0.150 |
Why?
|
Pneumococcal Vaccines | 2 | 2013 | 397 | 0.150 |
Why?
|
Gout | 1 | 2024 | 619 | 0.140 |
Why?
|
Fee-for-Service Plans | 2 | 2020 | 705 | 0.140 |
Why?
|
Length of Stay | 2 | 2018 | 6472 | 0.140 |
Why?
|
Pneumococcal Infections | 2 | 2013 | 503 | 0.140 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2696 | 0.140 |
Why?
|
Problem-Based Learning | 1 | 2000 | 352 | 0.140 |
Why?
|
Education, Distance | 1 | 2000 | 259 | 0.140 |
Why?
|
Hospitals, General | 2 | 2011 | 795 | 0.140 |
Why?
|
Antibody Diversity | 1 | 1996 | 72 | 0.140 |
Why?
|
Immunocompromised Host | 2 | 2013 | 857 | 0.130 |
Why?
|
Incidence | 6 | 2024 | 21378 | 0.130 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2422 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2019 | 1256 | 0.130 |
Why?
|
Liver Diseases | 1 | 2005 | 1301 | 0.130 |
Why?
|
Hypolipidemic Agents | 1 | 2020 | 626 | 0.130 |
Why?
|
Splenectomy | 1 | 2017 | 391 | 0.130 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1999 | 1694 | 0.130 |
Why?
|
Quality Improvement | 4 | 2017 | 3840 | 0.130 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1822 | 0.130 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 499 | 0.130 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12532 | 0.130 |
Why?
|
Sex Factors | 3 | 2020 | 10530 | 0.130 |
Why?
|
Patient Readmission | 2 | 2021 | 3327 | 0.130 |
Why?
|
Genes, Immunoglobulin | 1 | 1996 | 287 | 0.130 |
Why?
|
Cerebrovascular Disorders | 1 | 2022 | 1500 | 0.120 |
Why?
|
Advance Care Planning | 1 | 2023 | 697 | 0.120 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 90 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3159 | 0.120 |
Why?
|
Immunoglobulin Variable Region | 1 | 1996 | 419 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2000 | 830 | 0.120 |
Why?
|
Hospitals, Teaching | 2 | 2011 | 1166 | 0.120 |
Why?
|
Quality Assurance, Health Care | 4 | 2011 | 2178 | 0.120 |
Why?
|
DNA Primers | 1 | 1999 | 2819 | 0.120 |
Why?
|
Age Factors | 4 | 2020 | 18415 | 0.120 |
Why?
|
Myocardium | 2 | 2011 | 4688 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1300 | 0.120 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3870 | 0.110 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 5201 | 0.110 |
Why?
|
Medicare Part C | 1 | 2019 | 322 | 0.110 |
Why?
|
Online Systems | 1 | 2014 | 181 | 0.110 |
Why?
|
Lung Diseases | 1 | 2003 | 1915 | 0.110 |
Why?
|
Patient Admission | 4 | 2008 | 1384 | 0.110 |
Why?
|
Heart | 1 | 2006 | 4392 | 0.110 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 41 | 0.100 |
Why?
|
Systole | 1 | 2015 | 947 | 0.100 |
Why?
|
Calciphylaxis | 1 | 2014 | 130 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7809 | 0.100 |
Why?
|
Coronary Angiography | 1 | 2024 | 4560 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2005 | 3023 | 0.100 |
Why?
|
Uremia | 1 | 2013 | 201 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2273 | 0.100 |
Why?
|
Disease Progression | 3 | 2022 | 13505 | 0.100 |
Why?
|
Video Games | 1 | 2014 | 190 | 0.100 |
Why?
|
Prognosis | 3 | 2019 | 29636 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39254 | 0.100 |
Why?
|
Medicare | 2 | 2020 | 6771 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2646 | 0.090 |
Why?
|
Outpatients | 2 | 2017 | 1606 | 0.090 |
Why?
|
Social Class | 1 | 2020 | 2005 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3598 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15273 | 0.090 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2016 | 734 | 0.090 |
Why?
|
Terminal Care | 1 | 2023 | 1759 | 0.090 |
Why?
|
Hospital Departments | 1 | 2011 | 136 | 0.090 |
Why?
|
Stroke | 3 | 2017 | 9945 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2011 | 164 | 0.090 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2011 | 232 | 0.090 |
Why?
|
Aspirin | 1 | 2022 | 3365 | 0.090 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9388 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3870 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2024 | 64947 | 0.080 |
Why?
|
Systems Integration | 1 | 2011 | 426 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6499 | 0.080 |
Why?
|
Patients' Rooms | 1 | 2009 | 62 | 0.080 |
Why?
|
Prevalence | 3 | 2017 | 15687 | 0.080 |
Why?
|
Medical Record Linkage | 1 | 2010 | 289 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2011 | 2753 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2255 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 619 | 0.080 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2010 | 198 | 0.080 |
Why?
|
Stroke Volume | 2 | 2022 | 5513 | 0.080 |
Why?
|
Observation | 1 | 2010 | 312 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 253 | 0.080 |
Why?
|
Dictionaries as Topic | 1 | 2007 | 11 | 0.080 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 11902 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 14656 | 0.070 |
Why?
|
Quality Control | 1 | 2010 | 827 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2640 | 0.070 |
Why?
|
Odds Ratio | 2 | 2017 | 9712 | 0.070 |
Why?
|
Research Report | 1 | 2010 | 370 | 0.070 |
Why?
|
Heart Rate | 1 | 2019 | 4169 | 0.070 |
Why?
|
Education, Medical | 1 | 1999 | 1728 | 0.070 |
Why?
|
Medical Audit | 1 | 2008 | 453 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 349 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2283 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1927 | 0.070 |
Why?
|
Critical Pathways | 1 | 2009 | 475 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2916 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3381 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2311 | 0.060 |
Why?
|
Efficiency | 1 | 2008 | 477 | 0.060 |
Why?
|
Self Care | 1 | 2010 | 793 | 0.060 |
Why?
|
Risk Assessment | 4 | 2020 | 24086 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 474 | 0.060 |
Why?
|
Drug Utilization | 1 | 2010 | 1195 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2010 | 966 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.060 |
Why?
|
Radiation Oncology | 1 | 2010 | 563 | 0.060 |
Why?
|
Hospital Information Systems | 1 | 2007 | 396 | 0.060 |
Why?
|
Diagnosis | 1 | 2005 | 157 | 0.060 |
Why?
|
Medical Staff, Hospital | 1 | 2008 | 600 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1208 | 0.060 |
Why?
|
Software Design | 2 | 2006 | 171 | 0.060 |
Why?
|
Electronics | 1 | 2005 | 317 | 0.060 |
Why?
|
Rheumatic Diseases | 1 | 2010 | 639 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3483 | 0.050 |
Why?
|
Aortic Valve | 2 | 2024 | 1996 | 0.050 |
Why?
|
Patient Discharge | 3 | 2011 | 3475 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2003 | 662 | 0.050 |
Why?
|
Liver Function Tests | 1 | 2003 | 524 | 0.050 |
Why?
|
Cholestasis | 1 | 2005 | 374 | 0.050 |
Why?
|
Databases, Nucleic Acid | 1 | 2002 | 204 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2003 | 437 | 0.050 |
Why?
|
Bilirubin | 1 | 2003 | 438 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9282 | 0.050 |
Why?
|
Income | 1 | 2010 | 1876 | 0.050 |
Why?
|
Echocardiography | 2 | 2024 | 4980 | 0.050 |
Why?
|
Pituitary Apoplexy | 1 | 2001 | 29 | 0.050 |
Why?
|
Databases, Protein | 1 | 2002 | 388 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2009 | 6242 | 0.040 |
Why?
|
Hepatitis, Chronic | 1 | 2000 | 52 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5876 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20048 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4900 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 9070 | 0.040 |
Why?
|
DNA Restriction Enzymes | 1 | 1999 | 553 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2006 | 1534 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4409 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2003 | 665 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2002 | 2178 | 0.040 |
Why?
|
Uric Acid | 1 | 2024 | 807 | 0.040 |
Why?
|
Sodium | 1 | 2003 | 1601 | 0.040 |
Why?
|
Death | 1 | 2023 | 678 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2138 | 0.040 |
Why?
|
Attitude to Computers | 1 | 1999 | 195 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2000 | 1628 | 0.040 |
Why?
|
F Factor | 1 | 2017 | 12 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2006 | 2325 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4168 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2013 | 22041 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 165 | 0.040 |
Why?
|
Biotechnology | 1 | 1999 | 281 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1215 | 0.030 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2016 | 13 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1918 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3242 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5201 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 917 | 0.030 |
Why?
|
Expert Testimony | 1 | 2019 | 361 | 0.030 |
Why?
|
Turtles | 1 | 1996 | 40 | 0.030 |
Why?
|
Cocaine-Related Disorders | 1 | 2000 | 460 | 0.030 |
Why?
|
Base Sequence | 2 | 1999 | 12447 | 0.030 |
Why?
|
Feedback | 1 | 2000 | 791 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2005 | 4814 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11891 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2022 | 1797 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 1999 | 13456 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2019 | 641 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1996 | 778 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15680 | 0.030 |
Why?
|
Dyspnea | 1 | 2003 | 1352 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10552 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10829 | 0.030 |
Why?
|
Demography | 1 | 2000 | 1650 | 0.030 |
Why?
|
Primary Prevention | 1 | 2023 | 1207 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2000 | 1833 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 12915 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2011 | 7854 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 495 | 0.030 |
Why?
|
Electric Countershock | 1 | 2017 | 537 | 0.030 |
Why?
|
Drug Design | 1 | 1999 | 1062 | 0.030 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2014 | 146 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1996 | 649 | 0.030 |
Why?
|
Audiovisual Aids | 1 | 2014 | 99 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2235 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 58673 | 0.030 |
Why?
|
Multigene Family | 1 | 1996 | 1079 | 0.030 |
Why?
|
Prospective Studies | 3 | 2017 | 54263 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3822 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2017 | 784 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1025 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3112 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2167 | 0.030 |
Why?
|
Lipids | 1 | 2003 | 3336 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2001 | 1313 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22025 | 0.030 |
Why?
|
Educational Measurement | 1 | 1999 | 1249 | 0.020 |
Why?
|
Adolescent | 1 | 2020 | 87747 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13629 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2011 | 260 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3466 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12762 | 0.020 |
Why?
|
Information Systems | 1 | 2013 | 398 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2161 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4172 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4361 | 0.020 |
Why?
|
Diet, Sodium-Restricted | 1 | 2011 | 291 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5726 | 0.020 |
Why?
|
Alcoholism | 1 | 2000 | 1961 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7512 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 884 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3924 | 0.020 |
Why?
|
Angiotensin II | 1 | 2011 | 850 | 0.020 |
Why?
|
Communication | 1 | 2023 | 3846 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2016 | 1798 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12968 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2011 | 335 | 0.020 |
Why?
|
Animals | 4 | 2011 | 167940 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7468 | 0.020 |
Why?
|
Cardiology | 1 | 2019 | 1723 | 0.020 |
Why?
|
Models, Organizational | 1 | 2011 | 545 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2002 | 0.020 |
Why?
|
Seizures | 1 | 2000 | 2916 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6067 | 0.020 |
Why?
|
Rheumatology | 1 | 2013 | 611 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12806 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16543 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9629 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2014 | 1802 | 0.020 |
Why?
|
Program Development | 1 | 2011 | 1297 | 0.010 |
Why?
|
Physician's Role | 1 | 2011 | 920 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15827 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2042 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2009 | 820 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2017 | 2755 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81216 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2006 | 536 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17628 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7803 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2469 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5324 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3726 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2011 | 1416 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2011 | 3537 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2006 | 936 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18968 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13300 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8553 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23363 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 25928 | 0.000 |
Why?
|
Recurrence | 1 | 2001 | 8487 | 0.000 |
Why?
|
Neoplasms | 1 | 2014 | 22066 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 36247 | 0.000 |
Why?
|